Miami Biotech Collective
Miami Biotech Collective is a Miami-based, founder-led membership organization founded in 2025 that convenes South Florida's biotech founders, investors, and operators through curated events, the Annual Summit, and the MBC Think Tank, funded by membership fees and tiered corporate sponsorships.
- Company typePrivate
- Founded2025
- HeadquartersMiami, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Miami Biotech Collective does
Miami Biotech Collective (MBC) is a Miami-based, founder-led membership organization founded in 2025 that convenes South Florida's biotech leaders—founders, CEOs, investors, operators, academics, and public-sector stakeholders—into a curated community addressing the fragmentation of the regional biotech ecosystem. The core product is an application-based membership program that grants access to networking events, roundtables, the MBC Think Tank for ecosystem research, and a flagship set of convenings. The flagship event is the Annual Summit (inaugurated December 2025 during Miami Art Week with 150+ attendees), complemented by a 2026 calendar that includes the Oppenheimer x MBC CNS Summit, a Welcome to Miami Reception with BIO International, and a Formula 1 weekend event with Leerink Partners. Other products include the Leadership Roundtable Series (co-hosted with the Miami-Dade Beacon Council), member-only power lunches, and two advisory bodies: the Board of Advisors and the Women's Leadership Council.
MBC's revenue model rests on three streams: individual membership fees (annual, application-based, pricing not publicly disclosed), tiered corporate sponsorships (Gold, Silver, Bronze annual corporate partners including J.P. Morgan, Oppenheimer, Catalyst Pharmaceuticals, LaVoie Health Science, McKinney, INmune Bio, ScholarRock, Zevra Therapeutics, and Cognition Therapeutics), and event revenue from summit registrations and branded programming partnerships. The organization is operationally lean (1-10 employees, anchored by Founder and President Raquel Cabo and Operations and Membership Manager Fernanda Gamero, supported by interns and Strategic Communications Fellows) and uses a community-led go-to-market model in which growth is driven by word-of-mouth, partnerships with regional economic development and industry bodies, and signature-event visibility. The organization is not a technology company: no proprietary platform, AI, or integrations are disclosed, and the core deliverable is curated human connectivity and ecosystem signaling rather than a software product.
Miami Biotech Collective firmographics
Firmographics- Name
- Miami Biotech Collective
- Legal name
- Miami Biotech Collective
- Website
- https://miamibiotechcollective.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Miami Biotech Collective is a Miami-based, founder-led membership organization founded in 2025 that convenes South Florida's biotech founders, investors, and operators through curated events, the Annual Summit, and the MBC Think Tank, funded by membership fees and tiered corporate sponsorships.
- Ownership category
- akta.pro rank
Miami Biotech Collective industry classification
Industry- Product category
- Biotech Industry Community and Networking Services
- NAICS
- Convention and Trade Show Organizers (56192), Business Associations (813910)
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Life Sciences & Biotechnology Congresses (THAHAJAB)
- akta.pro secondary industries
- Medical, Scientific & Healthcare Congress Organizers (THAHACAD), Industry-Specific B2B Trade Show Organizers (THAHABAB)
Keywords
Where Miami Biotech Collective is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Miami Biotech Collective business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Others
Revenue model
- Membership Fees: Annual membership fees for individuals and corporate sponsors seeking access to the biotech community network, events, and resources.
- Corporate Sponsorships: Tiered corporate sponsorship packages (Gold, Silver, Bronze) providing brand visibility, event access, and ecosystem engagement opportunities for biotech companies and service providers.
- Event Revenue: Revenue from summit registrations, event tickets, and branded programming partnerships.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Individual Membership - Access to community network and events |
| Subscription | Annual | Corporate Sponsorship - Tiered packages with brand visibility and event access |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Miami Biotech Collective product offering
Product offeringCore offering
Miami Biotech Collective operates a curated membership community that convenes South Florida's biotech operators, founders, investors, and academic leaders through its membership program, Annual Summit, Leadership Roundtable Series, and MBC Think Tank. Members gain access to networking events, exclusive roundtables, ecosystem research, and corporate-sponsored programming. The organization is funded through individual membership fees, corporate sponsorships, and event revenue.
Product overview
Miami Biotech Collective is a community organization offering a unified portfolio of membership programs and events. The core offering is the membership program, which provides access to networking events, roundtables, exclusive gatherings, and the MBC Think Tank for ecosystem insights. The flagship event is the Annual Summit, complemented by the Leadership Roundtable Series and member gatherings. The organization also provides strategic guidance through its Board of Advisors and Women's Leadership Council. The products work together to build social capital, reputational capital, and economic capital for South Florida's biotech ecosystem.
Differentiator
Problem solved
Functional benefit
Products and services
- Miami Biotech Collective Membership A curated membership program providing access to South Florida's biotech community, including networking events, roundtables, exclusive gatherings, and the MBC Think Tank for ecosystem insights and research. Targets biotech executives, founders, investors, and operators.
- Annual Summit The flagship annual event featuring panels, discussions, and networking for biotech CEOs, investors, founders, and ecosystem leaders focused on building and financing biotech companies in South Florida.
- Leadership Roundtable Series Invitation-only executive roundtables convening biotech and healthcare leaders, investors, public-sector leaders, and healthcare systems for closed-door discussions on Miami's emerging role as a biotech hub.
- MBC Think Tank A member benefit providing access to perspectives, research, and ecosystem data to support company growth and career development within South Florida's biotech ecosystem.
Quantifiable outcome
- 700+ community members representing the South Florida biotech ecosystem
- +2 more outcomes
Companies that use Miami Biotech Collective
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles3 records
Miami Biotech Collective technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Miami Biotech Collective partnerships and signals
Strategic signalPartnerships
20 partnerships are on record, tiered core and supporting.
- OppenheimercoreGold Annual Corporate Partner. Co-hosts the Oppenheimer x MBC CNS Summit in June 2026 following the Goldman Sachs Investment Conference. This exclusive CNS Summit convenes senior executives and investors in neurotherapeutics.
- Catalyst PharmaceuticalscoreGold Annual Corporate Partner. CEO Rich Daly serves on MBC's Board of Advisors. Company sponsors the Annual Summit and ecosystem events.
- INmune BiocoreSilver Annual Corporate Partner. CEO David Moss serves on MBC's Board of Advisors. Company participates in summits and ecosystem programming.
- LaVoie Health SciencecoreGold Annual Corporate Partner. Healthcare communications agency providing strategic support for MBC's thought leadership and visibility initiatives.
- McKinneycoreGold Annual Corporate Partner. Marketing and communications firm supporting MBC's brand and event visibility.
- Discover InternationalsupportingGold Annual Corporate Partner. Company engaged with MBC's ecosystem development initiatives.
- ScholarRocksupportingSilver Annual Corporate Partner. Biotech company engaged with South Florida ecosystem.
- Zevra TherapeuticssupportingSilver Annual Corporate Partner. Biotech company engaged with MBC's programming and events.
- Cognition TherapeuticssupportingSilver Annual Corporate Partner. Biotech company supporting the biotech ecosystem in South Florida.
- Lowenstein SandlercoreLegal Counsel and Bronze partner. Provides legal guidance and support for MBC's operations and events.
- Russo PartnerscoreMedia Representative and Strategic Supporter. Healthcare communications firm representing MBC and providing PR services. President David Schull and SVP Ignacio Guerrero-Ros serve on Board of Advisors.
- Miami-Dade Beacon CouncilcoreCo-hosts Leadership Roundtable Series with MBC. Economic development organization driving Miami's biotech ecosystem growth. Closed-door discussions produce white papers on Miami's biotech value proposition.
- BIO InternationalcoreCo-hosts Welcome to Miami Reception preceding the BIO Innovation and Growth Summit. MBC serves as local host for visiting biotech executives.
- Nucleate FloridasupportingCo-hosts educational networking events including 'Why Florida? The Future of Biotech Entrepreneurship' panel discussion. Partnership engages student and early-career biotech community.
- Leerink PartnerssupportingCo-hosts 'The Biotech Fast Lane: From Track to Technology' event during Formula 1 Miami Grand Prix weekend. Exclusive gathering at intersection of science, sport, and human performance.
- University of Florida / UF InnovatesupportingUF Innovate is a Summit sponsor. University represented in MBC programming through figures like Jackson Streeter (Partner, DeepWork Capital / UF Innovate Ventures) and Duane Mitchell (Associate Dean, UF Clinical & Translational Science Institute).
- Sylvester Comprehensive Cancer CentersupportingSummit sponsor. Director Stephen Nimer participates in panel discussions on building biotech in South Florida.
- Baptist Health Cancer CaresupportingSummit sponsor. Healthcare system contributing to Miami's clinical research and biotech ecosystem infrastructure.
- OrricksupportingLegal sponsor for 'The Art of the Patient' reception at the 2025 Summit. Law firm supporting healthcare and biotech clients.
- MintzsupportingSponsor for the 2026 Oppenheimer x MBC CNS Summit.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Miami Biotech Collective competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Miami Biotech Collective social profiles
Digital presenceMiami Biotech Collective financial estimates
Financial estimateRevenue estimate
Valuation estimate
Miami Biotech Collective leadership team
Management profileNumber of profiles
Profiles6 records
Miami Biotech Collective funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Miami Biotech Collective M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Miami Biotech Collective
What does Miami Biotech Collective do?
Miami Biotech Collective operates a curated membership community that convenes South Florida's biotech operators, founders, investors, and academic leaders through its membership program, Annual Summit, Leadership Roundtable Series, and MBC Think Tank. Members gain access to networking events, exclusive roundtables, ecosystem research, and corporate-sponsored programming. The organization is funded through individual membership fees, corporate sponsorships, and event revenue.
Is Miami Biotech Collective a public or private company?
Miami Biotech Collective is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Miami Biotech Collective founded?
Miami Biotech Collective was founded in 2025. It employs 1 to 10 people.
Where is Miami Biotech Collective based?
Miami Biotech Collective is headquartered in Miami, United States, in the North America region.
How does Miami Biotech Collective make money?
Three revenue lines are on record. Membership Fees are the primary driver. The others are corporate Sponsorships and event Revenue.
Does Miami Biotech Collective have an API?
No public API is recorded for Miami Biotech Collective.
What industry is Miami Biotech Collective in?
Miami Biotech Collective's product category is Biotech Industry Community and Networking Services. Its primary akta.pro industry code is THAHAJAB, Life Sciences & Biotechnology Congresses, with a secondary code of THAHACAD, Medical, Scientific & Healthcare Congress Organizers. Its NAICS code is 56192 and its SIC code is 8600.